Sclerostin epitopes

Details for Australian Patent Application No. 2006242476 (hide)

Owner UCB Pharma S.A. Amgen, Inc.

Inventors Hoffmann, Kelly Sue; Henry, Alistair James; Winters, Aaron George; Winkler, David; Robinson, Martyn Kim; Lu, Hsieng Sen; Lawson, Alastair; Paszty, Christopher; Latham, John

Agent Davies Collison Cave

Pub. Number AU-B-2006242476

PCT Pub. Number WO2006/119062

Priority 60/792,645 17.04.06 US; 60/677,583 03.05.05 US; 60/782,244 13.03.06 US; 60/776,847 24.02.06 US; 11/410,540 25.04.06 US

Filing date 28 April 2006

Wipo publication date 9 November 2006

Acceptance publication date 31 May 2012

International Classifications

C07K 14/51 (2006.01) Peptides having more than 20 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119062 Priority application(s): WO2006/119062

31 May 2012 Application Accepted

  Published as AU-B-2006242476

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242478-Long-chain quaternary ammonium compounds as wood treatment agents

2006242475-HCV NS3 protease inhibitors